Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP498013.RAPMSAR1vRnHE1qURqb-u7KEldCevHfvnw55Pw066leLI130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP498013.RAPMSAR1vRnHE1qURqb-u7KEldCevHfvnw55Pw066leLI130_assertion type Assertion NP498013.RAPMSAR1vRnHE1qURqb-u7KEldCevHfvnw55Pw066leLI130_head.
- NP498013.RAPMSAR1vRnHE1qURqb-u7KEldCevHfvnw55Pw066leLI130_assertion wasGeneratedBy ECO_0000203 NP498013.RAPMSAR1vRnHE1qURqb-u7KEldCevHfvnw55Pw066leLI130_provenance.
- NP498013.RAPMSAR1vRnHE1qURqb-u7KEldCevHfvnw55Pw066leLI130_assertion wasDerivedFrom befree-20140225 NP498013.RAPMSAR1vRnHE1qURqb-u7KEldCevHfvnw55Pw066leLI130_provenance.
- NP498013.RAPMSAR1vRnHE1qURqb-u7KEldCevHfvnw55Pw066leLI130_assertion SIO_000772 21552124 NP498013.RAPMSAR1vRnHE1qURqb-u7KEldCevHfvnw55Pw066leLI130_provenance.
- NP498013.RAPMSAR1vRnHE1qURqb-u7KEldCevHfvnw55Pw066leLI130_assertion evidence source_evidence_literature NP498013.RAPMSAR1vRnHE1qURqb-u7KEldCevHfvnw55Pw066leLI130_provenance.
- NP498013.RAPMSAR1vRnHE1qURqb-u7KEldCevHfvnw55Pw066leLI130_assertion description "[Radiation and chemotherapy have low response rates in WDLS and DDLS, but novel agents targeted at chromosome 12 gene products MDM2 and CDK4 have shown promise in preclinical studies and are being tested in clinical trials.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP498013.RAPMSAR1vRnHE1qURqb-u7KEldCevHfvnw55Pw066leLI130_provenance.